- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07228845
Effectiveness Comparison of 3D-Printed and Conventional Ear Tip Comfort in Individuals With Hearing Loss
April 30, 2026 updated by: Bryan Wong, University of Arizona
Access to affordable and timely hearing healthcare remains a major challenge for many individuals, partly due to the high cost and long turnaround time.
This study will explore whether 3D-printed ear tips perform as well as or better than standard ear tips in terms of sound quality, comfort, and fit over a prolonged duration in a sample of individuals with bilateral hearing loss.
It will also compare how long each method takes to make and how much each costs.
Study Overview
Status
Recruiting
Study Type
Interventional
Enrollment (Estimated)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bryan Wong, AuD, PhD
- Phone Number: 5206268549 16025270359
- Email: bryanwong@arizona.edu
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85721
- Recruiting
- The University of Arizona Hearing Clinic
-
Contact:
- Bryan Wong, AuD, PhD
- Phone Number: 5206268549
- Email: bryanwong@arizona.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Bilateral, symmetric, sensorineural hearing loss, with thresholds between normal and severe degree of hearing loss
- Normal otoscopy: patent ear canals with normal appearing eardrums and aerated middle ear, bilaterally.
- English speaking.
Exclusion Criteria:
- Self reported history of extensive or current outer or middle ear pathology.
- Self reported history of extensive outer or middle ear surgery.
- Self reported history of neurological or cognitive disorder.
- Active ear infection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: In-house Study group_Resin
participants will initially receive ear tips fabricated using biocompatible resin
|
Hearing aids will be fit with three different types of customized ear tips.
They will wear each ear tip for 1 week.
The following order participants will wear each ear tip includes: Resin, Third-party, FlexResin.
Hearing aids will be programmed to fit the participants' hearing loss from 250-8000Hz.
A short washout period will follow completion of testing with ear tip group
|
|
Active Comparator: Third-party Manufactured
participants will initially receive ear tips fabricated by third party manufacturer using biocompatible resin
|
Hearing aids will be fit with three different types of customized ear tips.
They will wear each ear tip for 1 week.
The following order participants will wear each ear tip includes: Third-party, FlexResin, Resin.
Hearing aids will be programmed to fit the participants' hearing loss from 250-8000Hz.
A short washout period will follow completion of testing with ear tip group.
|
|
Experimental: In-house Study group_FlexibleResin
Participants will initially receive ear tips fabricated using biocompatible flexible resin
|
Hearing aids will be fit with three different types of customized ear tips.
They will wear each ear tip for 1 week.
The following order participants will wear each ear tip includes: Resin, Third-party, FlexResin.
Hearing aids will be programmed to fit the participants' hearing loss from 250-8000Hz.
A short washout period will follow completion of testing with ear tip group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Outer EAR comfort questionnaire
Time Frame: through study completion, an average of 1 week
|
A validated questionnaire, Outer EAR, will be used to elicit patient perception of physical comfort, acoustic comfort, quality of voice, and overall self-perceived satisfaction.
Includes 6 items (5 levels) , with 5 representing best possible function/rating.
|
through study completion, an average of 1 week
|
|
Real Ear Measures
Time Frame: through study completion, an average of 1 week
|
Evaluation of ear canal acoustics with participant wearing a hearing aid and eartip type (3d party, in-house_Resin, in-house_FlexResin).
A thin microphone tube is placed in the ear canal to measure the average amount gain (dB SPL) across various frequencies (250-8000Hz) while the participant sits in front of a speaker playing sound samples.
Results are recorded in gain (dB SPL) across frequencies.
|
through study completion, an average of 1 week
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cost
Time Frame: through study completion, an average of week
|
The total raw cost ($, dollars US)
|
through study completion, an average of week
|
|
Time
Time Frame: through study completion, an average of week
|
Time-to-subject for each ear tip type
|
through study completion, an average of week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 15, 2026
Primary Completion (Estimated)
April 15, 2027
Study Completion (Estimated)
April 25, 2027
Study Registration Dates
First Submitted
November 7, 2025
First Submitted That Met QC Criteria
November 13, 2025
First Posted (Actual)
November 14, 2025
Study Record Updates
Last Update Posted (Actual)
May 1, 2026
Last Update Submitted That Met QC Criteria
April 30, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5737
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Aids
-
University of ArizonaCompletedHearing AidsUnited States
-
Sodra Alvsborgs HospitalCompleted
-
Sodra Alvsborgs HospitalCompleted
-
University of ArizonaRecruitingHearing Aids | 3D PrintingUnited States
-
University of Colorado, DenverNational Institute on Deafness and Other Communication Disorders (NIDCD)RecruitingHearing Loss | Hearing Aids | OTC Hearing AidsUnited States
-
Indiana UniversityWithdrawnHearing Loss, Sensorineural | Speech | Hearing AidsUnited States
-
Northwestern UniversityLeslie Rolph; Tom Wardzala; Malini Patel; Tracy Winn; Larry E. Humes; Mary MeskanCompletedHearing Loss | Hearing AidsUnited States
-
VA Office of Research and DevelopmentCompletedNormal Hearing | Tinnitus | Hearing AidsUnited States
-
Pamukkale UniversityCompletedHearing Loss | Bone Anchored Hearing AidsTurkey
-
Oticon MedicalRecruitingHearing Loss | Bone Anchored Hearing AidsSweden